Search Results 721-730 of 19277 for Hemoglobin

  1. Study of Magrolimab Combination Therapy to Treat Unresectable, Locally Advanced or Metastatic Triple-Negative Breast Cancer - Mayo Clinic

    hemoglobin inclusion criteria. - History of hemolytic anemia, autoimmune thrombocytopenia, or Evans syndrome in the last 3 months. - Prior treatment with ...

  2. Study of 177Lu-PSMA-617 In Metastatic Castrate-Resistant Prostate Cancer - Mayo Clinic

    Hemoglobin ≥ 9 g/dL (9 g/dL is equivalent to 90 g/L and 5.59 mmol/L). Hepatic: Total bilirubin ≤ 1.5 x the institutional upper limit of normal (ULN). For ...

  3. Dose-Escalated Photon IMRT or Proton Beam Radiation Therapy Versus Standard-Dose Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma - Mayo Clinic

    Hemoglobin ≥ 10.0 g/dl (note: the use of transfusion or other intervention to achieve hemoglobin (Hgb) ≥ 10.0 g/dl is acceptable); Bilirubin ≤ 1.5 upper ...

  4. A Phase 2, Multi-center, Open-label Study to Evaluate the Efficacy and Safety of Luspatercept (ACE-536) in Subjects with Myeloproliferative Neoplasm-Associated Myelofibrosis and Anemia with and without Red Blood Cell-Transfusion Dependence - Mayo Clinic

    No subjects with an interval ≥ 42 days between hemoglobin measurements will be enrolled;; There must not be any RBC transfusions within the 84-day period ...

  5. A Study Of Ex Vivo Expansion (ACT-X) - Mayo Clinic

    The following laboratory values obtained ≤ 28 days prior to registration. Hemoglobin ≥910.0 g/dl. Absolute neutrophil count (ANC) ≥1500/mm3. Platelet count ...

  6. A Study of the Effect of Dalcetrapib on Cardiovascular Risk for a Genetically Defined Population who have had a Recent Acute Coronary Syndrome Event - Mayo Clinic

    Last known hemoglobin <10 g/dL; Index ACS event presumed due to uncontrolled hypertension. Participating Mayo Clinic locations. Study statuses change often ...

  7. A Vaccine (H2NVAC) Before Surgery for the Treatment of HER2-Expressing Ductal Carcinoma In Situ - Mayo Clinic

    * Hemoglobin \>= 9.0 g/dL (less than or equal to 28 days prior to registration) * Creatinine =\< 2 x upper limit of normal (ULN) (less than or equal to 28 ...

  8. Auranofin and Sirolimus in Treating Participants With Ovarian Cancer - Mayo Clinic

    Obtained =< 14 days prior to registration: Hemoglobin (Hgb) >= 9 g/dL; Obtained =< 14 days prior to registration: Total bilirubin =< 1.5 x upper limit of ...

  9. Autologous, MUC1-Activated T Cells Expanded From Peripheral Blood in Patients With Relapsed and Resistant Ovarian Cancer - Mayo Clinic

    Hemoglobin ≥ 8.0 g/dL;; Platelet count ³30,000/mm3;; Total bilirubin ≤2.0 mg/dL unless patient has documented Gilbert's syndrome (Subjects with Gilbert's ...

  10. A Study Of The Effect, Safety, And Tolerability Of LJPC-501 In Patients With Catecholamine-Resistant Hypotension - Mayo Clinic

    Active bleeding AND hemoglobin < 7g/dL or any other condition that would contraindicate serial blood sampling; An absolute neutrophil count (ANC) of < 1000 ...